Navigation Links
Congenital rubella syndrome nearly eradicated in the US

Congenital rubella syndrome, a birth defect caused by the rubella virus (also known as German measles), has practically been eliminated in the U.S., according to a statement published in the April 2006 issue of Birth Defects Research Part A, the official journal of The Teratology Society. The journal is available online via Wiley InterScience at http://www3.interscience.wiley.com/cgi-bin/jhome/102526943.

Endorsed by the Teratology Society, the Organization of Teratology Information Specialists (OTIS), the Neurobehavioral Teratology Society, and the Behavioral Toxicology Society, the statement notes that rubella is no longer an endemic disease in this country and congenital rubella syndrome "is almost a thing of the past in the United States." Birth defects resulting from rubella may include blindness, deafness, and congenital heart disease. A rubella epidemic in the early 1960s caused more than 11,000 fetal deaths and 20,000 infants to be born with congenital rubella syndrome, but a more effective vaccine introduced in the 1970s has helped in eliminating transmission of rubella from expectant mothers to their unborn babies.

"Effectively, congenital rubella syndrome has been nearly eradicated from the United States," according to the statement. There were fewer than 10 cases or rubella reported in the U.S. last year and in the past 5 years there have only been 4 cases of congenital rubella syndrome reported, only one of which was in a child whose mother had been born in the U.S.

The remarkable success of the immunization program to eliminate rubella is due to joint efforts by the Centers for Disease Control and Prevention, various state and local health departments, the American Academy of Pediatrics, the American College of Obstetrics and Gynecology, and the March of Dimes, according to the statement. Maintaining high rubella immunization rates is crucial to the continue d success of these efforts. The statement concludes: "Effective strategies, such as continued universal childhood and adolescent immunization, must be secured to extend this success worldwide."


'"/>

Source:John Wiley & Sons, Inc.


Related biology news :

1. 15-year hunt finds cause of pseudothalidomide syndrome
2. Gene for immune deficiency syndromes found
3. Removing DNA repair gene causes metabolic syndrome
4. Researchers link two more genes to sudden infant death syndrome
5. Down syndrome: Its not just the age factor
6. A potential biological cause for sudden infant death syndrome
7. Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows
8. Angelman syndrome deficits rescued in mice
9. Chronic fatigue syndrome impairs a persons slow wave activity during sleep
10. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
11. Breast tumors in mice eradicated using cancer vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/22/2016)... Dec. 20, 2016  As part of its longstanding mission ... personal genetics company, recently released its latest children,s book, titled ... book focuses on the topics of inheritance and variation of ... (NGSS) taught in elementary school classrooms in the US. ... by illustrator Ariana Killoran , whose previous book with ...
(Date:12/16/2016)... 2016   IdentyTechSolutions America LLC , a ... solutions and a cutting-edge manufacturer of software and ... offering seamless, integrated solutions that comprise IDT biometric ... solutions provide IdentyTech,s customers with combined physical identification ... crime and theft. "We are proud ...
(Date:12/15/2016)... ... Markets has announced the addition of the "Global Military Biometrics Market ... the global military biometrics market to grow at a CAGR of 7.5% ... based on an in-depth market analysis with inputs from industry experts. The ... years. The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... DrugDev ... Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). DrugDev will join ... clinical research issues such as trial performance metrics, patient enrollment diversity, protocol optimization, ...
(Date:1/18/2017)... -- HUYA Bioscience International, (HUYA), the leader in accelerating the ... innovations, announced today a strategic collaboration agreement with the ... to as CAS Innovation). The collaboration will focus on ... at CAS to meet the medical needs of patients ... company to have recognized China,s ...
(Date:1/17/2017)... ... 17, 2017 , ... MS Technologies™ and Bayer have received ... Performance System will combine industry-leading genetics with a double herbicide-tolerant trait that will ... Bean herbicide. The Balance™ GT Soybean Performance System will benefit soybean growers by ...
(Date:1/17/2017)... , Jan. 17, 2017   Pulmatrix, Inc . ... company developing innovative inhaled therapies to address serious pulmonary ... fungal infections in the lungs of CF patients, PUR1900, ... (QIDP) by the U.S. Food & Drug Administration. ... designed to speed the development of novel drugs against ...
Breaking Biology Technology: